Mitsubishi UFJ Asset Management
HAE icon

Mitsubishi UFJ Asset Management’s Haemonetics HAE Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58K Hold
61
– – ﹤0.01% 1561
2026
Q1 		$3.44K Hold
61
– – ﹤0.01% 1548
2025
Q4 		$4.88K Hold
61
– – ﹤0.01% 1486
2025
Q3 		$2.97K Hold
61
– – ﹤0.01% 1552
2025
Q2 		$4.55K Hold
61
– – ﹤0.01% 1480
2025
Q1 		$3.88K Hold
61
– – ﹤0.01% 1491
2024
Q4 		$4.88K Hold
61
– – ﹤0.01% 1447
2024
Q3 		$4.9K Hold
61
– – ﹤0.01% 1421
2024
Q2 		$5.05K Hold
61
– – ﹤0.01% 1370
2024
Q1 		$5.21K Hold
61
– – ﹤0.01% 1327
2023
Q4 		$4.98K Hold
61
– – ﹤0.01% 1306
2023
Q3 		$5.46K Buy
+61
New +$5.45K ﹤0.01% 1244

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Asset Management's HAE Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Haemonetics (HAE) position steady in Q2 2026 at 61 shares worth $4.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1561.

Mitsubishi UFJ Asset Management first reported a position in HAE in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.46K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 61 shares of Haemonetics worth $4.58K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1561 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Haemonetics in Q3 2023 and has held it in 12 quarters since.
  • Mitsubishi UFJ Asset Management's Haemonetics position peaked at $5.46K in Q3 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.